Reply To: Clinical Supply Return Reconciliation
September 24, 2020 at 10:12 amHas anyone established a direct-from-patient return process? DtP has been really hot in 2020 but what about a trial that has traditional site distribution but the final visit is just a phone call? Patients will not visit the site to be able to return their final drug supply. Has anyone planned for this? This is a US only trial. Other than ensuring HIPPA compliance/concerns what other pitfalls need to be avoided? Should the trial go global, what other concerns are there?
